Commission Implementing Decision (EU) 2017/1387 of 24 July 2017 authorising the placing on the market of an enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 4975)
Commission Implementing Decision (EU) 2017/1387 of 24 July 2017 authorising the placing on the market of an enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 4975)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Without prejudice to Directive 2002/46/EC, the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger as specified in Annex I to this Decision may be placed on the Union market as a novel food ingredient to be used in food supplements intended for the general adult population with a maximum dose established in Annex II to this Decision.
The designation of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger authorised by this Decision on the labelling of the foodstuffs shall be ‘prolyl oligopeptidase’.
ANNEX I
Specifications of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger
Specification of the enzyme
Systematic name
Prolyl oligopeptidase
Synonyms
Prolyl endopeptidase, proline-specific endopeptidase, endoprolylpeptidase
Molecular weight
66 kDa
Enzyme Commission number
EC 3.4.21.26
CAS number
72162-84-6
Source
A genetically modified strain of Aspergillus niger (GEP-44)
Description : Prolyl oligopeptidase is available as an enzyme preparation containing approximately 30 % maltodextrin.
Specifications of the enzyme preparation of prolyl oligopeptidase
Parameter
Specifications Limits
Activity
> 580 000 PPI ( 1 ) /g (> 34,8 PPU ( 2 ) /g)
Appearance
Microgranulate
Colour
Off-white to orange yellowish. The colour may change from batch to batch
Dry Matter
> 94 %
Gluten
< 20 ppm
Heavy metals
Total heavy metals (as lead)
≤ 10 mg/kg
Lead
≤ 1,0 mg/kg
Arsenic
≤ 1,0 mg/kg
Cadmium
≤ 0,5 mg/kg
Mercury
≤ 0,1 mg/kg
Microbiological specifications
Total aerobic plate count
≤ 10 3 CFU/g
Total yeasts and moulds
≤ 10 2 CFU/g
Sulphite reducing anaerobes
≤ 30 CFU/g
Enterobacteriaceae
< 10 CFU/g
Salmonella
Absent in 25 g
Escherichia coli
Absent in 25 g
Staphylococcus aureus
Absent in 10 g
Pseudomonas aeruginosa
Absent in 10 g
Listeria monocytogenes
Absent in 25 g
Antimicrobial activity
Absent
Mycotoxins
Below limits of detection: Aflatoxin B1, B2, G1, G2 (< 0,25 μg/kg), total Aflatoxins (< 2,0 μg/kg), Ochratoxin A (< 0,20 μg/kg), T-2 Toxin (< 5 μg/kg), Zearalenone (< 2,5 μg/kg), Fumonisin B1 and B2 (< 2,5 μg/kg)
( 1 ) PPI — Protease Picomole International.
( 2 ) PPU — Prolyl Peptidase Units or Proline Protease Units.
ANNEX II
Authorised uses of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger
Food category
Maximum dose
Food supplements as defined in Directive 2002/46/EC
120 PPU ( 1 ) /day (2,7 g of enzyme preparation/day) (2 × 10 6 PPI ( 2 ) /day) for general adult population
( 1 ) PPU — Prolyl Peptidase Units or Proline Protease Units.
( 2 ) PPI — Protease Picomole International.